The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.
about
The role of MRI in prostate cancer diagnosis and management.Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy.Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS).Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI.Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.Summary statement on screening for prostate cancer in Europe.Imaging: MRI improves cost and accuracy of prostate cancer biopsy.Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.What is an acceptable false negative rate in the detection of prostate cancer?Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50
P2860
Q30245245-8027C638-EC6C-441D-8C47-1317CDCFE834Q36946259-04DB1B04-7F0E-463D-8980-11104B6303FDQ38708189-C3308901-89BA-4F46-B66E-0021B6A60A09Q38957244-323CFB91-AED2-4F80-AAD7-143EE71EE96CQ39174624-EC8B3ADE-D84A-4D4E-A690-360B74839615Q39191190-C67F33A0-A361-4A12-91E5-0BA1EA3B8322Q39356200-6D77D907-F633-4C1F-A0AA-3873AF7308C8Q47120053-4D429693-0668-4708-A7A3-0C3BE14BD941Q47393127-5DE894C7-B132-4E18-87A3-846BCF3487B5Q47811496-B9D58D97-7CA1-40A1-B260-13F1C677D2F7Q47901606-1C91B35A-4F91-4B7C-B5BD-AE276CFC1A77Q50109408-4BD6B23C-C206-43CC-A08A-AE74681194DDQ50422339-BC4E9A5E-3B2E-4CE2-BFE2-996A4952578FQ52624221-0255E388-5152-4E67-9299-20F4CA272B14Q53058454-E26B6B21-98F2-431A-97CE-8D741C6781ECQ57107312-DE2B79E7-861A-413A-8486-8BF8E0EFCFACQ57484099-E05C8493-65FA-48FB-ADC5-D4CB6D92E873
P2860
The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Diagnostic Performance of ...... t Significant Prostate Cancer.
@en
type
label
The Diagnostic Performance of ...... t Significant Prostate Cancer.
@en
prefLabel
The Diagnostic Performance of ...... t Significant Prostate Cancer.
@en
P2093
P50
P1476
The Diagnostic Performance of ...... ct Significant Prostate Cancer
@en
P2093
A M Haynes
J E Thompson
M Pulbrook
P J van Leeuwen
W Delprado
P304
P356
10.1016/J.JURO.2015.10.140
P407
P577
2015-10-31T00:00:00Z